Reflections on the 2017 ACR Congress

This year the American College of Rheumatology (ACR) annual scientific congress took place in the city of San Diego, CA. Those who have regularly attended the ACR meetings will undoubtedly have remembered previous editions in this beautiful city. Each time one visits San Diego it is striking how much it develops, and just as striking […]

Read More…

The 2016 ACR congress

The ACR congress also featured, as it always does, a lot of exciting activities and new findings on SLE. Lupus gives up its secrets only very slowly, but there were many presentations from researchers working on elucidating the etiology and pathophysiology of this disease. I was most impressed by results from different groups that point […]

Read More…

Professor Ronald van Vollenhoven about Lupus Science & Medicine

Professor Ronald van Vollenhoven is the Head of the Department of Medicine, Unit for Clinical Therapy Research, Inflammatory Diseases (ClinTRID) at Karolinska Institutet in Stockholm, Sweden, and one of the Editors-in-chief for Lupus Science & Medicine.   – Professor van Vollenhoven, we have heard you many times encouraging the rheumatologists to treat to target, both […]

Read More…

Challenges in understanding the role of pregnancy morbidity in cardiovascular risk in SLE

Dialogue by Julia F Simard and Jinoos Yazdany. Originally published here. Cardiovascular disease (CVD) is a leading cause of morbidity and mortality in systemic lupus erythematosus (SLE).1 Despite extensive and ongoing research in this area, few risk factors, including traditional ones such as smoking and hypertension, explain a significant proportion of the risk. There is a robust scientific […]

Read More…